Improving health outcomes through regulatory excellence

Symposium working parties

The working parties for our Symposium streams are responsible for developing their respective programmes, selecting topics and speakers, and ensuring that the content is relevant, exciting and informative. Their members are made up of industry experts who are committed to knowledge-sharing and professional development.

Human Medicines working party



Francesca Buttigieg
Director of Regulatory Affairs
PTC Therapeutics, Inc.
Switzerland

  

Sabine Haubenreisser
Principal Scientific Administrator
EMA
Germany

Carla Jonker
Senior Regulatory Project Leader/
Scientific Administrator, EMA
The Netherlands

Maren Koban
Director, Global Regulatory and
Scientific Policy, Merck Group
Germany


Carlos Langezaal
Senior Director Regulatory Affairs
Premier Research
United States

Andrea Laslop
Head of Scientific Office
AGES
Austria

Sandra Lourenço
Director of Regulatory Affairs
Arriello
Ireland

Roelie Marinus
Senior Policy Advisor
CBG/MEB
The Netherlands 


Fred Senatore 
Lead Physician
FDA
United States

Almath Spooner
Head of Europe Regulatory Policy and Intelligence
AbbVie
Ireland

Josephine Tapper
Lay advisor - Medicines and Healthcare Products Regulatory Agency (MHRA) and EUPATI fellow
United Kingdon		  

Marie Uguen
SVP, Regulatory Affairs & Quality Assurance
SparingVision
France 

TOPRA Symposium 2024
Postillion Hotel & Convention Centre WTC Rotterdam,
Beursplein 37, Meent 110,
3011 AA Rotterdam, Netherlands

Contact us
meetings@topra.org
+44 (0)20 7510 2560

#TOPRASym24

 

Exhibition / Sponsorship
Call +44 (0)20 7510 2573
or email erik@topra.org

No content found

No content found

TOPRA Symposium 2024
Postillion Hotel & Convention Centre WTC Rotterdam,
Beursplein 37, Meent 110,
3011 AA Rotterdam, Netherlands

Contact us
meetings@topra.org
+44 (0)20 7510 2560

#TOPRASym24

Exhibition / Sponsorship
Call +44 (0)20 7510 2573
or email erik@topra.org